Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

369 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Core outcome measurement set for research and clinical practice in post-COVID-19 condition (long COVID) in children and young people: an international Delphi consensus study "PC-COS Children".
Seylanova N, Chernyavskaya A, Degtyareva N, Mursalova A, Ajam A, Xiao L, Aktulaeva K, Roshchin P, Bobkova P, Aiyegbusi OL, Anbu AT, Apfelbacher C, Asadi-Pooya AA, Ashkenazi-Hoffnung L, Brackel C, Buonsenso D, de Groote W, Diaz JV, Dona D, Dunn Galvin A, Genuneit J, Goss H, Hughes SE, Jones CJ, Kuppalli K, Malone LA, McFarland S, Needham DM, Nekliudov N, Nicholson TR, Oliveira CR, Schiess N, Segal TY, Sigfrid L, Thorne C, Vijverberg S, Warner JO, Were WM, Williamson PR, Munblit D; PC-COS Children Study Group. Seylanova N, et al. Among authors: apfelbacher c. Eur Respir J. 2024 Mar 14;63(3):2301761. doi: 10.1183/13993003.01761-2023. Print 2024 Mar. Eur Respir J. 2024. PMID: 38359962 Free PMC article. Review.
Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus study.
Gorst SL, Seylanova N, Dodd SR, Harman NL, O'Hara M, Terwee CB, Williamson PR, Needham DM, Munblit D, Nicholson TR; PC-COS study group. Gorst SL, et al. Lancet Respir Med. 2023 Dec;11(12):1101-1114. doi: 10.1016/S2213-2600(23)00370-3. Epub 2023 Nov 2. Lancet Respir Med. 2023. PMID: 37926103 Review.
Measuring Signs of Atopic Dermatitis in Clinical Practice: A HOME-CP Consensus Statement.
Jacobson ME, Leshem YA, Apfelbacher C, Spuls PI, Gerbens LAA, Thomas KS, Williams HC, Katoh N, Howells L, Schmitt J, Deckert S, Seshadri R, Simpson EL; Harmonising Outcome Measures for Eczema (HOME) initiative. Jacobson ME, et al. Among authors: apfelbacher c. JAMA Dermatol. 2024 Aug 1;160(8):878-886. doi: 10.1001/jamadermatol.2024.1162. JAMA Dermatol. 2024. PMID: 38776110
A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema.
Petersen RS, Fijen LM, Apfelbacher C, Magerl M, Weller K, Aberer W, Adatia A, Audhya P, Bara NA, Betschel S, Boccon-Gibod I, Bouillet L, Brodszki N, Busse PJ, Buttgereit T, Bygum A, Cancian M, Craig T, Csuka D, Farkas H, Fomina D, Gil-Serrano J, Gompels M, Guidos Fogelbach G, Guilarte M, Hide M, Kiani-Alikhan S, Kinaciyan T, Lenten A, Lleonart R, Longhurst H, Lumry WR, Malbran A, Malinauskiene L, Matta Campos JJ, Mendivil J, Nieto-Martinez SA, Peter JG, Porebski G, Reshef A, Riedl M, Valerieva A, Waserman S, Maurer M, Cohn DM. Petersen RS, et al. Among authors: apfelbacher c. J Allergy Clin Immunol Pract. 2024 Jun;12(6):1614-1621. doi: 10.1016/j.jaip.2024.04.007. Epub 2024 Apr 11. J Allergy Clin Immunol Pract. 2024. PMID: 38609017 Free article.
[Prioritization of research questions in health crises-presentation of a concept developed during the COVID-19 pandemic].
Ziegler A, Kunzler AM, Voigt-Radloff S, Schmitt J, Moerer O, Scheithauer S, Heytens H, Apfelbacher C, Meerpohl JJ. Ziegler A, et al. Among authors: apfelbacher c. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Dec 5. doi: 10.1007/s00103-024-03985-4. Online ahead of print. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024. PMID: 39636443 Review. German.
Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS, Apfelbacher CA, Chalmers JR, Simpson E, Spuls PI, Gerbens LAA, Williams HC, Schmitt J, Gabes M, Howells L, Stuart BL, Grinich E, Pawlitschek T, Burton T, Howie L, Gadkari A, Eckert L, Ebata T, Boers M, Saeki H, Nakahara T, Katoh N. Thomas KS, et al. Among authors: apfelbacher ca. Br J Dermatol. 2020 Nov 11. doi: 10.1111/bjd.19673. Online ahead of print. Br J Dermatol. 2020. PMID: 33179283
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.
Leshem YA, Chalmers JR, Apfelbacher C, Katoh N, Gerbens LAA, Schmitt J, Spuls PI, Thomas KS, Howells L, Williams HC, Simpson EL; Harmonising Outcome Measures for Eczema (HOME) initiative. Leshem YA, et al. Among authors: apfelbacher c. JAMA Dermatol. 2022 Dec 1;158(12):1429-1435. doi: 10.1001/jamadermatol.2022.4211. JAMA Dermatol. 2022. PMID: 36223090
Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.
Thomas KS, Apfelbacher CA, Chalmers JR, Simpson E, Spuls PI, Gerbens LAA, Williams HC, Schmitt J, Gabes M, Howells L, Stuart BL, Grinich E, Pawlitschek T, Burton T, Howie L, Gadkari A, Eckert L, Ebata T, Boers M, Saeki H, Nakahara T, Katoh N. Thomas KS, et al. Among authors: apfelbacher ca. Br J Dermatol. 2021 Jul;185(1):139-146. doi: 10.1111/bjd.19751. Epub 2021 Feb 8. Br J Dermatol. 2021. PMID: 33393074 Free PMC article.
369 results